BridgeMD
New treatment option for Multiple Sclerosis
Official title The Effect of a Mediterranean Diet on Quality of Life in Multiple Sclerosis Patients
ClinicalTrials.gov ID: NCT06764563
What this study is testing
- What it's testing
- The role of dietary interventions in improving symptoms of multiple sclerosis (MS) is of high interest amongst patients and researchers, but data supporting this evidence are limited. Current evidence indicates that A higher Expanded Disability Status Scale (EDSS) score correlates with poor diet quality in patients with MS.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 70
You may be able to join if
- Confirmed MS based on 2017 Mcdonald criteria, with stable medication regimen in the previous six months.
You likely can't join if
- Pregnancy or lactating
- People with a lack of judgment
- Serum creatinine ≥2 mg/dL(177 μmol per liter) or more
- Patients who had gastrointestinal problems that would prevent them from following any of the test diets
- Patients who had liver dysfunction (an increase by a factor of at least two above the upper limit of normal in alanine aminotransferase and aspartate...
- Active cancer or chemotherapy treatment in the last three years.
The study team makes the final eligibility decision.
Where it's taking place
- Tel Aviv, Israel, Israel
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 70 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Tel Aviv, Israel, Israel. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.